← Back to Search

Procedure

Hybrid L24 for Children

N/A
Waitlist Available
Led By Bruce J Gantz, MD
Research Sponsored by Bruce J Gantz
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-operatively through study completion (child is 5 years of age) or until the child scores 90% or better in all test conditions
Awards & highlights

Study Summary

This trial is testing whether a new cochlear implant that only stimulates part of the cochlea can provide useful hearing while preserving the rest of the cochlea for future advances.

Eligible Conditions
  • Children
  • Cochlear Implants
  • Bilateral Hearing Loss

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-operatively through study completion (child is 5 years of age) or until the child scores 90% or better in all test conditions
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-operatively through study completion (child is 5 years of age) or until the child scores 90% or better in all test conditions for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Phonetically Balanced-Kindergarten
The Early Speech Perception Four Choice Spondee and Monosyllable
The Glendonald Auditory Screening Procedure Word Test (GASP)
+2 more
Secondary outcome measures
Goldman-Fristoe Test of Articulation-2
Peabody Picture Vocabulary Development Scale (PPVT).
The Preschool Language Scale-3 (PLS-3)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Hybrid L24 and Standard CIExperimental Treatment1 Intervention
Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hybrid L24
2011
N/A
~20

Find a Location

Who is running the clinical trial?

Bruce J GantzLead Sponsor
2 Previous Clinical Trials
29 Total Patients Enrolled
Bruce J Gantz, MD4.114 ReviewsPrincipal Investigator - University of Iowa
University of Iowa
2 Previous Clinical Trials
44 Total Patients Enrolled
1Patient Review
My experience with this physician was unfortunately very poor. I found his staff to be rude and unprofessional, and he himself was arrogant and unhelpful. The medications he prescribed did nothing to improve my condition, and actually made it worse. I would not recommend him to anyone.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants
Bruce J Gantz 2011. "Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03156465.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top